The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
- Conditions
- Cervical Intraepithelial Neoplasia, Grade IIICervical Intraepithelial Neoplasia Grade IIHuman Papillomavirus Type 16
- Interventions
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2025-02-05
- Target Recruit Count
- 48
- Registration Number
- NCT04131413
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery
- Conditions
- AnalgesiaSurgery
- Interventions
- Other: Thoracic epidural analgesia (bupivacaine)
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2025-04-23
- Target Recruit Count
- 106
- Registration Number
- NCT04117074
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
- Conditions
- Colorectal CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2025-04-29
- Target Recruit Count
- 30
- Registration Number
- NCT04117087
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer
- Conditions
- Pancreatic Cancer Non-resectablePancreatic Cancer Metastatic
- Interventions
- Drug: INCMGA00012 (PD-1 antibody)
- First Posted Date
- 2019-10-04
- Last Posted Date
- 2024-12-09
- Target Recruit Count
- 25
- Registration Number
- NCT04116073
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
- Conditions
- High Tumor Mutation BurdenHigh TMB (Tumor Mutation Burden)MSS (Microsatellite Stable)
- Interventions
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2025-03-30
- Target Recruit Count
- 12
- Registration Number
- NCT04098068
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
SBRT as a Vaccination for Metastatic Melanoma
- Conditions
- Metastatic Melanoma
- Interventions
- Radiation: Stereotactic Body Radiation Therapy (SBRT)
- Locations
- 🇺🇸
Johns Hopkins Bayview, Baltimore, Maryland, United States
🇺🇸The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, Maryland, United States
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
- Conditions
- Prostate Cancer
- Interventions
- Radiation: stereotactic ablative radiotherapy (SABR)
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 64
- Registration Number
- NCT04037358
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2025-04-04
- Target Recruit Count
- 15
- Registration Number
- NCT04019964
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
- Conditions
- Oropharynx CancerHPV-Related CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Mount Sinai School of Medicine, The Tisch Cancer Institute, New York, New York, United States
🇺🇸Mount Sinai School of Medicine, New York, New York, United States
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
- Conditions
- High Grade GliomaBRAF V600EBRAF V600KAnaplastic AstrocytomaAnaplastic Pleomorphic XanthoastrocytomaGliosarcomaGlioblastoma
- Interventions
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2024-10-31
- Target Recruit Count
- 5
- Registration Number
- NCT03973918
- Locations
- 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States